A deeper understanding of the mechanisms that control responses to inflammation is critical to the development of effective therapies. We sought to define the most proximal regulators of the Cullin-Ring-Ligases (CRL), which play a central role in the stabilization of NF-κB and HIF. In these studies, we identify the human deneddylase-1 (SENP8) as a key regulator of Cullin neddylation response in vitro and in vivo. Using human microvascular endothelial cells (HMEC), we examined inflammatory responses to LPS or TNF-α by assessing Cullin-neddylation status, NF-κB and HIF-1α stabilization and inflammatory cytokine secretion. HMEC with an intact neddylation pathway showed a time-dependent induction of Cullin-1 (Cul-1) neddylation, nuclear translocation of NF-κB, stabilization of HIF-1α and increased NF-κB/HIF-α promoter activity in response to LPS. HMEC cells lacking SENP8 were unable to neddylate Cul-1 and subsequently were unable to activate NF-κB or HIF-1α. Pharmacological targeting of neddylation (MLN4924) significantly abrogated NF-κB responses, induced HIF-1α promoter activity and reduced secretion of TNF-α-elicited pro-inflammatory cytokines. MLN4924 stabilized HIF and abrogated pro-inflammatory responses while maintaining anti-inflammatory IL-10 response in vivo, following LPS administration. These studies identify SENP8 as a proximal regulator of Cullin neddylation and provide an important role for SENP8 in fine-tuning of the inflammatory response. Moreover, our findings provide feasibility for therapeutic targeting of the Cullins during inflammation.